You are using an outdated browser. Please upgrade your browser to improve your experience.

ranibizumab

Ligand Summary
Description
A recombinant humanized monoclonal antibody fragment that binds VEGF-A to prevent its binding to VEGFR-1 and VEGFR-2 receptors. This activity reduces vessel permeability and angiogenesis in the treatment of neovascular age-related MACULAR DEGENERATION.
Synonyms & Links
ChEMBL: CHEMBL1201825
DrugCentral: 4971
LyCHI:  ranibizumab


Target Activities